ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,615.35
      0.55%
      US Tech 100
      19,804.00
      0.64%
      Dow Jones
      40,000.90
      0.62%
      Brent Oil
      84.57
      0.00%
      Bitcoin
      60,230.65
      1.68%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Lexicon Pharmaceuticals Inc (LXRX)

      7. Lexicon Pharmaceuticals Inc (LXRX) News

      LXRX

      Lexicon Pharmaceuticals (LXRX)

      Lexicon Pharmaceuticals Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:LXRX
      DateTimeSourceHeadlineSymbolCompany
      09/24/20207:13AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/23/20206:43PMGlobeNewswire Inc.Lexicon Pharmaceuticals Reaches Agreements to Exchange Convertible Notes, Reduce Outstanding IndebtednessNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/11/20204:12PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/08/20205:03PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/08/20204:05PMGlobeNewswire Inc.Lexicon Pharmaceuticals Completes the Sale of XERMELO to TerSera TherapeuticsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/04/20208:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Commencement of Patient Dosing in RELIEF-DPN-1 Phase 2 Clinical Study of LX9211 in Patients...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      09/03/20206:00PMGlobeNewswire Inc.Lexicon Pharmaceuticals to Participate in the Citi 15ᵗʰ Annual BioPharma Virtual Conference and the Wells Fargo 2020 Virtu...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/04/20206:00AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      08/03/20207:25AMPR Newswire (US)GTCR and TerSera Therapeutics Announce Acquisition of XermeloNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20207:19AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20207:15AMGlobeNewswire Inc.Lexicon Realigns Business Around Research and Development Assets, with Focus on Phase 2 LX9211 Neuropathic Pain ProgramNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20207:10AMGlobeNewswire Inc.Lexicon Pharmaceuticals Enters Into Agreement With TerSera Therapeutics for the Sale of XERMELONASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20207:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/30/20207:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Reports Second Quarter 2020 Financial Results and Provides a Business UpdateNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/29/20205:08PMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/29/20204:57PMEdgar (US Regulatory)Quarterly Report (10-q)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/23/20207:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Host Second Quarter 2020 Financial Results Conference Call and Webcast on July 30, 2020NASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/21/20207:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Topline Phase 3 Data From Four Phase 3 Sotagliflozin Studies in Type 2 DiabetesNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/20/20207:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Poster Presentations at the Virtual Cholangiocarcinoma Foundation Annual ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      07/15/20205:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      06/13/202011:01AMGlobeNewswire Inc.Lexicon Pharmaceuticals Presents Clinical Data at 80th American Diabetes Association Scientific SessionsNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/29/20204:35PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/27/20207:00AMGlobeNewswire Inc.Lexicon Pharmaceuticals to Present at Upcoming Investor ConferenceNASDAQ:LXRXLexicon Pharmaceuticals Inc
      05/13/20205:30PMGlobeNewswire Inc.Lexicon Pharmaceuticals Announces Preclinical Efficacy Data on Telotristat Ethyl’s Antiproliferative Effects Against Variou...NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20204:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20204:50PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20204:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20204:48PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20204:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
      04/27/20204:46PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:LXRXLexicon Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:LXRX